Click to see CEUS images of the liver, kidney and heart

CLICK HERE for updated information on Coding & Payment for CEUS, based on Medicare coding and national average payment amounts for CEUS.

Ultrasound can provide a safe and reliable imaging option for Covid-19 patients, and the addition of an ultrasound enhancing agent may be essential for evaluating heart and lung function.

CLICK HERE to find protocols for protecting personnel, disinfecting equipment, safely administering ultrasound contrast or enhancing agents, and appropriately imaging these highly vulnerable patients. Additional submissions may be sent to info@icus-society.org

ICUS supports the global ultrasound community during this rapidly evolving global crisis and extends heartfelt wishes for your safety and health as we come together to defeat this deadly virus.

ICUS is awaiting a decision on its Citizen Petition urging the FDA to remove “boxed warnings” on ultrasound contrast agents.

The ICUS petition cites a favorable risk-benefit profile, supported by new scientific studies demonstrating safety and efficacy. ICUS also cites precedent for reversal of “black boxes” when new data show that risks are less severe than previously thought.

The ICUS Citizen Petition is supported by statements filed by other ultrasound professional societies and CEUS experts.

CLICK HERE to read the ICUS Citizen Petition.

CLICK HERE to watch hands-on CEUS demonstrations performed by expert echocardiographers at the Hammersmith Echocardiology Conference in London. There is no cost to view the demonstrations.

Special thanks to ICUS board members Petros Nihoyannopoulos, Mark Monaghan and Sharon Mulvagh, and to LiveMedia, for making these educational experiences available to ICUS.

• SRU White Paper - CEUS - State of the Art in North America
• AIUM Programs - Click Here
• SDMS White Paper - Implementing a Liver Contrast Program - Click Here
• CEUS LI-Rads - Click Here
• Recent ESC guidelines - Chronic coronary syndrome - Click Here
• Rotterdam Presentation - Why should everybody use contrast for liver US? - Click Here

Introduction to CEUS for Abdominal Applications: Watch here

Introduction to CEUS for Echocardiography: Watch here

Special thanks to ICUS Board Member Bev Gorman, the Intersocietal Accreditation Commission, and speakers Cyndi Peterson and Pam Burgess.

ICUS media release 4-23-21

Medical Society Urges Use of Ultrasound Contrast Agents and Supports Safety Record

ICUS today urged physicians to use ultrasound contrast agents (UCAs) to enhance conventional ultrasound images where medically appropriate, with customary protocols in place to address rare allergic reactions that may occur in one out of ten thousand doses.

Read full release here

Enhanced ultrasound imaging beats CT and MR for diagnosing some liver cancers

ICUS urges FDA to Remove Boxed Warnings on Ultrasound Contrast Agents - cites citing compelling scientific data demonstrating their safety and life-saving potential.

More Doctors Are Turning to Radiation-free CEUS Scans for Imaging Children Says ICUS

Microbubbles and Ultrasound Can Help Treat Heart Attacks

CEUS Safely Assesses Suspected Liver Tumors in Pregnant Women

CEUS Helps Diagnose Infant Brain Injury and Predict Outcomes

Tiny Bubbles Help Doctors Predict Risk of Heart Attack and Stroke

Simple CEUS Scan Helps Diagnose Liver Cancer When MRI is Uncertain

Ultrasound Societies Urge FDA to Remove “Black Box” on Ultrasound Contrast Agents

Physicians predict “sea change” for contrast ultrasound use

More ICUS Press Releases

The ICUS Bubble Blog showcases real-life CEUS experiences from around the world, with a special focus on how CEUS impacts individual patients and their care.

CEUS predicts benign versus malignant liver mass

By Garvit Devmohan Khatri MBBS Fellow Abdominal Imaging, Department of Radiology, University of Washington, Seattle, WA

Mr. Y is a 48-year-old healthy man who noticed palpable tiny lumps near his armpits and immediately sought medical attention.  His physician ordered a biopsy, which indicated a low-grade malignancy known as “epithelioid hemangioendothelioma’ -- often found in many parts of the body, including the liver and lungs, at the same time.

A follow up CT scan was performed to screen for other masses. It showed an indeterminate small 1 cm mass in the right lower aspect of the liver. Then a follow up MR exam was performed for further evaluation and to exclude more smaller masses that may not be well visible with CT. The MR scan did not show more masses but showed targetoid appearance of the known liver mass without showing all the imaging features of an epithelioid hemangioendothelioma. With these inconclusive findings, an ultrasound guided biopsy was needed.

Click here to continue.

More Bubble Blogs

• CEUS allows patient to avoid expensive MRI and risky biopsy
• CEUS shows kidney mass is benign after CT suggests cancer
• CEUS stages liver cancer when CT and MRI unhelpful
• CEUS Excludes Kidney Mass
• UCA Alters Diagnosis and Treatment of COVID-Positive Patient
• CEUS Helps Rule Out Gallbladder Cancer
• CEUS helps rule out pancreatic cancer
• Young girl recovers from acute kidney failure after CEUS pinpoints cause
• CEUS rules out liver cancer where MR and CT were unsuccessful
• CEUS leads to life-saving surgery
• CEUS Identifies Ovarian Tumor
• More

To submit your CEUS story, please email info@icus-society.org.